India  

United States: Inching Toward Harmonization: FDA Finalizes Rule On IRB Waiver Of Informed Consent For Minimal Risk Studies - Ropes & Gray LLP

Mondaq Friday, 23 February 2024
On December 21, 2023, the U.S. Food and Drug Administration ("FDA") published a final rule to allow institutional review boards ("IRBs") to waive or alter informed consent for certain clinical...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Fluoride Exposed, New Vaccines + Stark Warnings | Feb 4 [Video]

Fluoride Exposed, New Vaccines + Stark Warnings | Feb 4

FDA approves clinical research without informed consent in situations of ‘minimal risk.’ Fluoride trials continue in the courts. Biotechnology innovations for warfare in the works. And that’s not..

Credit: Rumble     Duration: 16:18Published